Primary outcomes | | | | |
24 hours after procedure | | | | |
Recanalization on head CTA/MRA, n (%) | 48 (77.4) | 8 (25.8) | 9.9 (3.6 to 26.8) | <0.001 |
7 days after onset | | | | |
Survival, n (%) | 56 (90.3) | 17 (54.8) | 7.7 (2.6 to 23.1) | <0.001 |
Other outcomes | | | | |
7 days after onset | | | | |
mRS 0–2, n (%) | 10 (16.1) | 0 (0) | 0.6 (0.5, 0.7)* | 0.018 |
NIHSS (nIAT=56, nIVT=18), | 12.5 (8.0, 18.0) | 17.0 (12.8, 19.3) | N/A | 0.087 |
Median (IQR) | | | | |
90 days after onset, n (%) | | | | |
Survival | 55 (88.7) | 15 (48.4) | 8.4 (2.9 to 24.1) | <0.001 |
mRS 0–2 | 27 (43.5) | 2 (6.5) | 11.2 (2.5 to 51.1) | <0.001 |
NIHSS (nIAT=55, nIVT=15), Median (IQR) | 6.0 (3.0, 15.0) | 12.0 (6.0, 16.0) | N/A | 0.022 |
180 days after onset, n (%) | | | | |
Survival, n (%) | 53 (85.5) | 12 (38.7) | 9.3 (3.4 to 25.6) | <0.001 |
mRS 0–2, n (%) | 31 (50.0) | 2 (6.5) | 14.5 (3.2 to 66.1) | <0.001 |
NIHSS (nIAT=53, nIVT=12)* Median (IQR) | 4.0 (1.0, 12.0) | 11.5 (6.0, 16.0) | N/A | 0.016 |
Safety outcomes at 7 days after onset, n (%) | | | | |
Symptomatic hemorrhagic transformation | 3 (4.8) | 4 (12.9) | 0.3 (0.1 to 1.6) | 0.165 |
Asymptomatic hemorrhagic transformation | 12 (19.4) | 9 (29.0) | 0.6 (0.2 to 1.6) | 0.296 |